Woodgett's group is studying the molecular mechanisms by which the Wnt
and PI3K pathways are dysregulated in human cancers such as breast and
colon cancer. His laboratory is also studying the roles of signaling
pathways in type-2 diabetes and stem cell fate determination and has a
long-standing interest in genomics applications such as DNA microarrays
and protein arrays.